Hannah M. Linden

ScholarGPS® ID: 93692650846205

Affiliation

University of Washington, Seattle, United States

Affiliation History

Field

Medicine

Discipline

Oncology

Top Specialties

Metrics Summary

Publication Count

153

Predicted Citations

5,928

Predicted h-index

Ranking

Publications and Citation History

Publications based on Top Specialties

Types of Publication

Publications
Books
Patents
NIH/NSF

Add Delete
32P Genomic risk classification and whole transcriptome analysis of HR+/HER2- post-partum breast cancers: A FLEX sub study (journal article) Borges, V.F. \| Shagisultanova, E. \| O'Shaughnessy, J. \| Brufsky, A.M. \| Mahtani, R. \| Hoskins, K. \| Linden, H. \| D'Abreo, N. \| Uygun, S. \| Samraj, L. \| Audeh, W. ESMO Open, volume 9 (2024). 10.1016/j.esmoop.2024.103040 Cite \| Source
Repeatability of 18F-FDG uptake in metastatic bone lesions of breast cancer patients and implications for accrual to clinical trials (journal article) Muzi, Mark \| Peterson, Lanell M. \| Specht, Jennifer M. \| Hippe, Daniel S. \| Novakova-Jiresova, Alena \| Lee, Jean H. \| Kurland, Brenda F. \| Mankoff, David A. \| Obuchowski, Nancy \| Linden, Hannah M. \| Kinahan, Paul E. EJNMMI Research, volume 14, issue 1 (2024). 10.1186/s13550-024-01093-7 Cited by (1) \| Cite \| Source
What’s Moral Distress Got to Do With It? How to Avoid Burnout and Optimize Patient Care (journal article) He, Bowen \| Finkelstein, Claudia A \| Symonds, Lynn \| Uy, Natalie F \| Linden, Hannah M International Journal of Cancer Care and Delivery (2024). 10.53876/001c.94856 Cite \| Source
Activity and safety of enobosarm, a novel, oral, selective androgen receptor modulator, in androgen receptor-positive, oestrogen receptor-positive, and HER2-negative advanced breast cancer (Study G200802): a randomised, open-label, multicentre, multinatio (journal article) Palmieri, Carlo \| Linden, Hannah \| Birrell, Stephen N \| Wheelwright, Sally \| Lim, Elgene \| Schwartzberg, Lee S \| Dwyer, Amy R \| Hickey, Theresa E \| Rugo, Hope S \| Cobb, Patrick \| ... \| Overmoyer, Beth The Lancet Oncology, volume 25, issue 3, pages 317-325 (2024). 10.1016/S1470-2045(24)00004-4 Cited by (3) \| Cite \| Source
Alcohol, Smoking, and Risks of Breast Cancer Recurrence and Mortality among Women with Luminal, Triple-Negative, and HER2-Overexpressing Breast Cancer (journal article) Loroña, Nicole C. \| Othus, Megan \| Malone, Kathleen E. \| Linden, Hannah M. \| Tang, Mei-Tzu C. \| Li, Christopher I. Cancer Epidemiology, Biomarkers & Prevention, volume 33, issue 2, pages 288-297 (2024). 10.1158/1055-9965.EPI-23-1081 Cited by (1) \| Cite \| Source
Summary: SNMMI Procedure Standard/EANM Practice Guideline for Estrogen Receptor Imaging of Patients with Breast Cancer Using 16α-[18 F]Fluoro-17β-Estradiol PET (journal article) Mankoff, David \| Balogová, Soňa \| Dunnwald, Lisa \| Dehdashti, Farrokh \| DeVries, Erik \| Evangelista, Laura \| Van Kruchten, Michel \| Vaz, Sofia Carrilho \| Fowler, Amy \| Linden, Hannah \| Ulaner, Gary A. Journal of Nuclear Medicine, volume 65, issue 2, pages 221-223 (2024). 10.2967/jnumed.123.266938 Cited by (5) \| Cite \| Source
Fluorine-18-Labeled Fluoroestradiol PET/CT: Current Status, Gaps in Knowledge, and Controversies—AJR Expert Panel Narrative Review (journal article) Covington, Matthew F. \| O'Brien, Sophia R. \| Lawhn-Heath, Courtney \| Pantel, Austin R. \| Ulaner, Gary A. \| Linden, Hannah M. \| Dehdashti, Farrokh American Journal of Roentgenology (2023). 10.2214/AJR.23.30330 Cited by (1) \| Cite \| Source
Multimodal prediction of neoadjuvant treatment outcome by serial FDG PET and MRI in women with locally advanced breast cancer (journal article) Kazerouni, Anum S. \| Peterson, Lanell M. \| Jenkins, Isaac \| Novakova-Jiresova, Alena \| Linden, Hannah M. \| Gralow, Julie R. \| Hockenbery, David M. \| Mankoff, David A. \| Porter, Peggy L. \| Partridge, Savannah C. \| Specht, Jennifer M. Breast Cancer Research, volume 25, issue 1 (2023). 10.1186/s13058-023-01722-4 Cited by (3) \| Cite \| Source
Experiences of patients with metastatic breast cancer: A qualitative study. (journal article) Hunter, Natasha \| English, Sarah \| Nguyen, Vina \| Vinayak, Shaveta \| Linden, Hannah M. \| Specht, Jennifer M. \| Gwin, William R \| Yung, Rachel Lynn \| Al Achkar, Morhaf JCO Oncology Practice, volume 19, issue 11_suppl, pages 346-346 (2023). 10.1200/OP.2023.19.11_suppl.346 Cite \| Source
Estrogen Receptor-Targeted and Progesterone Receptor-Targeted PET for Patients with Breast Cancer (journal article) Ulaner, Gary A. \| Fowler, Amy M. \| Clark, Amy S. \| Linden, Hannah PET Clinics, volume 18, issue 4, pages 531-542 (2023). 10.1016/j.cpet.2023.04.008 Cited by (4) \| Cite \| Source
Dual Prognostic Classification of Triple-Negative Breast Cancer by DNA Damage Immune Response and Homologous Recombination Deficiency (journal article) Stecklein, Shane R. \| Barlow, William \| Pusztai, Lajos \| Timms, Kirsten \| Kennedy, Richard \| Logan, Gemma E. \| Seitz, Rob \| Badve, Sunil \| Gökmen-Polar, Yesim \| Porter, Peggy \| ... \| Sharma, Priyanka JCO Precision Oncology (2023). 10.1200/PO.23.00197 Cited by (1) \| Cite \| Source
Long term survival in patients with bony oligometastatic breast cancer treated with curative intent: An institutional case series. (journal article) Iancu, Alexandra \| Vinayak, Shaveta \| Gwin, William R \| Linden, Hannah M. \| Specht, Jennifer M. \| Symonds, Lynn Katherine \| Davidson, Nancy E. \| Hunter, Natasha Journal of Clinical Oncology, volume 41, issue 16_suppl, pages e12574-e12574 (2023). 10.1200/JCO.2023.41.16_suppl.e12574 Cite \| Source
Incidental discovery of second primary malignancies in patients diagnosed with breast cancer: An institutional case series. (journal article) Iancu, Alexandra \| Manohar, Poorni \| Vinayak, Shaveta \| Gwin, William R. \| Linden, Hannah M. \| Specht, Jennifer M. \| Symonds, Lynn Katherine \| Davidson, Nancy E. \| Hunter, Natasha Journal of Clinical Oncology, volume 41, issue 16_suppl, pages e12552-e12552 (2023). 10.1200/JCO.2023.41.16_suppl.e12552 Cited by (1) \| Cite \| Source
Can Molecular Imaging Find a Path to Navigate Evolving Breast Cancer Treatments? (journal article) Linden, Hannah M. \| Mankoff, David A. Clinical Cancer Research, volume 29, issue 11, pages 2015-2016 (2023). 10.1158/1078-0432.CCR-23-0393 Cited by (1) \| Cite \| Source
Summary: Appropriate Use Criteria for Estrogen Receptor–Targeted PET Imaging with 16α-18 F-Fluoro-17β-Fluoroestradiol (journal article) Ulaner, Gary A. \| Mankoff, David A. \| Clark, Amy S. \| Fowler, Amy M. \| Linden, Hannah M. \| Peterson, Lanell M. \| Dehdashti, Farrokh \| Kurland, Brenda F. \| Mortimer, Joanne \| Mouabbi, Jason \| ... \| de Vries, Elisabeth G.E. Journal of Nuclear Medicine, volume 64, issue 3, pages 351-354 (2023). 10.2967/jnumed.123.265420 Cited by (32) \| Cite \| Source
Secondary Breast Angiosarcoma After a Primary Diagnosis of Breast Cancer (journal article) Chau, Bonny \| Loggers, Elizabeth T. \| Cranmer, Lee D. \| Mogal, Harveshp \| Sharib, Jeremy M. \| Kim, Edward Y. \| Schaub, Stephanie K. \| Paulson, Kelly G. \| Linden, Hannah M. \| Specht, Jennifer M. \| ... \| Wagner, Michael J. American Journal of Clinical Oncology, volume 46, issue 12, pages 567-571 (2023). 10.1097/COC.0000000000001045 Cited by (1) \| Cite \| Source
Precision Medicine in Low- and Middle-Income Countries (journal article) Mathew Thomas, Vinay \| Linden, Hannah \| Gralow, Julie \| Van Loon, Katherine \| Williams, LaToya \| Dubard-Gault, Marianne \| Maria Lopez, Ana International Journal of Cancer Care and Delivery, volume 3, issue 2 (2023). 10.53876/001c.88504 Cite \| Source
The oral selective estrogen receptor degrader GDC-0810 (ARN-810) in postmenopausal women with hormone receptor-positive HER2-negative (HR + /HER2 −) advanced/metastatic breast cancer (journal article) Bardia, Aditya \| Mayer, Ingrid \| Winer, Eric \| Linden, Hannah M. \| Ma, Cynthia X. \| Parker, Barbara A. \| Bellet, Meritxell \| Arteaga, Carlos L. \| Cheeti, Sravanthi \| Gates, Mary \| ... \| Jhaveri, Komal Breast Cancer Research and Treatment, volume 197, issue 2, pages 319-331 (2023). 10.1007/s10549-022-06797-9 Cited by (13) \| Cite \| Source
Allogeneic hematopoietic cell transplantation in patients with a hematologic malignancy and a prior history of breast cancer (journal article) Doney, Kristine \| Leisenring, Wendy \| Linden, Hannah Breast Cancer Research and Treatment, volume 194, issue 3, pages 507-516 (2022). 10.1007/s10549-022-06658-5 Cite \| Source
AMEERA-1 phase 1/2 study of amcenestrant, SAR439859, in postmenopausal women with ER-positive/HER2-negative advanced breast cancer (journal article) Bardia, Aditya \| Chandarlapaty, Sarat \| Linden, Hannah M. \| Ulaner, Gary A. \| Gosselin, Alice \| Cartot-Cotton, Sylvaine \| Cohen, Patrick \| Doroumian, Séverine \| Paux, Gautier \| Celanovic, Marina \| ... \| Campone, Mario Nature Communications, volume 13, issue 1 (2022). 10.1038/s41467-022-31668-8 Cited by (32) \| Cite \| Source

Title	Investigators	Year	Cost	Agency
Advanced PET/CT Imaging for Improving Clinical Trials	Kinahan, Paul E \| Linden, Hannah M	2019	$612,217	NATIONAL CANCER INSTITUTE
Advanced PET/CT Imaging for Improving Clinical Trials	Kinahan, Paul E \| Linden, Hannah M	2018	$606,598	NATIONAL CANCER INSTITUTE
Advanced PET/CT Imaging for Improving Clinical Trials	Kinahan, Paul E \| Linden, Hannah M	2017	$648,569	NATIONAL CANCER INSTITUTE
Advanced PET/CT Imaging for Improving Clinical Trials	Linden, Hannah M \| Kinahan, PAUL E (contact)	2016	$656,737	NATIONAL CANCER INSTITUTE
Advanced PET/CT Imaging for Improving Clinical Trials	Linden, Hannah M \| Kinahan, PAUL E (contact)	2015	$693,233	NATIONAL CANCER INSTITUTE
Advanced PET/CT Imaging for Improving Clincail Trials	Linden, Hannah M \| Kinahan, PAUL E (contact)	2014	$539,050	NATIONAL CANCER INSTITUTE
Advanced PET/CT Imaging for Improving Clincail Trials	Linden, Hannah M \| Kinahan, PAUL E (contact)	2013	$532,690	NATIONAL CANCER INSTITUTE
Advanced PET/CT Imaging for Improving Clincail Trials	Mankoff, David A. \| Linden, Hannah M \| Kinahan, PAUL E (contact)	2012	$562,213	NATIONAL CANCER INSTITUTE
Advanced PET/CT Imaging for Improving Clincail Trials	Mankoff, David A. \| Linden, Hannah M \| Kinahan, PAUL E (contact)	2011	$565,840	NATIONAL CANCER INSTITUTE
Measures of Endocrine Sensitivity in Early Breast Cancer	Linden, Hannah M	2010	$472,260	NATIONAL CANCER INSTITUTE
Advanced PET/CT Imaging for Improving Clincail Trials	Mankoff, David A. \| Linden, Hannah M \| Kinahan, PAUL E (contact)	2010	$609,615	NATIONAL CANCER INSTITUTE
Measures of Endocrine Sensitivity in Early Breast Cancer	Linden, Hannah M	2009	$481,401	NATIONAL CANCER INSTITUTE
THROMBOPOIETIN STRUCTURE/FUNCTION	Linden, Hannah M	2001	$119,610	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES
THROMBOPOIETIN STRUCTURE/FUNCTION	Linden, Hannah M	2000	$119,610	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES
THROMBOPOIETIN STRUCTURE/FUNCTION	Linden, Hannah M	1999	$119,610	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES
THROMBOPOIETIN STRUCTURE AND FUNCTION	Linden, Hannah M	1997	$35,300	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES
THROMBOPOIETIN STRUCTURE AND FUNCTION	Linden, Hannah M	1996	$35,300	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES